Project Grant R44HG014445
Award Date
6/1/25
Completion Date
5/31/27
Dollars Obligated
$1M
Federal Agency
National Human Genome Research Institute
Federal Grant Program
93.172
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
This federal Project Grant award from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) supports the development of a revolutionary DNA sequencing platform by Xgenomes Corp. The goal is to create a super-resolution single-molecule sequencing technology that can read short sequence "words" rather than individual DNA bases, enabling high-density sequencing with greater accuracy and lower costs than existing methods. The $384,418 award will fund a...
This $1,234,692 Project Grant award from the National Human Genome Research Institute (NHGRI), under the 93.172 Human Genome Research Federal Grant Program, is supporting the development of a novel biomolecule imaging system called PRECYSE by Evizia Inc. The PRECYSE system leverages high-speed atomic force microscopy (HSAFM) to provide enhanced quality control capabilities for next-generation DNA sequencing library preparation. Key features include sizing DNA samples from 100 base pairs to...
The National Human Genome Research Institute (NHGRI), under the Human Genome Research Federal Grant Program (CFDA 93.172), awarded a $3,377,867 Project Grant to Survey Genomics, Inc. to develop and commercialize their innovative CYTOPE-DROP platform. This platform enables high-throughput, spatially-resolved single-cell multiomics analysis, allowing researchers to simultaneously profile mRNA abundances, protein abundances, and cell locations. The grant aims to further increase the spatial...
The federal Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) provides $1,507,500 to the University of Massachusetts Medical School (UMass Medical) to expand the capabilities of third-generation DNA/RNA sequencing technologies. The project aims to generate rapid and cost-effective training libraries to allow for direct detection of common DNA damage and RNA modifications, enabling innovative...
The National Human Genome Research Institute (NHGRI), under the Federal Grant Program "Human Genome Research" (CFDA 93.172), awarded a $407,291 Phase I Small Business Innovation Research (SBIR) grant to Electronic Biosciences, Inc. to develop a nanopore-based protein sequencing platform. The project aims to create a high-accuracy, label-free nanopore reader capable of direct, single-molecule protein sequencing. This novel technology would enable proteome-wide profiling, biomarker...
This federal Project Grant award of $743,524, awarded by the National Human Genome Research Institute (CFDA 93.172 Human Genome Research) and effective September 19, 2024, supports the development of "Expansion Genomics" - a new platform that leverages physical expansion of biological samples to increase the resolution of single-cell and spatial epigenomics techniques. The key objectives are to (1) develop "Single-Cell Expansion Genomics" to enable high-throughput,...
This $339,300 Project Grant awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) supports Triangle Biotechnology's development of a nanodroplet-enhanced sonication technology called ChromExtract. The goal is to enable high-quality, high-yield, and consistent chromatin extraction from formalin-fixed, paraffin-embedded (FFPE) tissue samples for downstream chromatin profiling and accessibility analyses. The...
This federal Project Grant award, provided by the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research), aims to develop a novel approach called Transcriptional Endpoint Marking (TEM) that can provide a comprehensive, genome-wide record of a cell's transcriptional history. The $2,293,200 award, granted to the University of Colorado-Denver, will fund the proof-of-concept development of the TEM technology and associated computational methods. This technology has the...
The Project Grant award R43HG013914, in the amount of $397,599.00, was provided by the National Human Genome Research Institute (NHGRI), under the Human Genome Research federal grant program (CFDA 93.172). The grant supports the development of a novel epigenetic analysis platform by Xgenomes Corp., a minority-owned for-profit company based in Cambridge, MA. The project aims to develop a single-molecule technology that can accurately detect DNA methylation patterns across the genome. This...
This federal Project Grant award, valued at $215,088.00 and made by the National Human Genome Research Institute (NHGRI) under the Human Genome Research (CFDA 93.172) program, supports the development of an innovative "next-generation mass spectrometry-based sequencing (NGMS-SEQ)" method for exhaustive de novo sequencing of all RNA species in a sample. The award aims to 1) further develop the NGMS-SEQ approach to directly identify and sequence every RNA molecule, including...